415 related articles for article (PubMed ID: 35884791)
21. Targeting gut microbiome: A novel and potential therapy for autism.
Yang Y; Tian J; Yang B
Life Sci; 2018 Feb; 194():111-119. PubMed ID: 29277311
[TBL] [Abstract][Full Text] [Related]
22. From Dysbiosis to Neurodegenerative Diseases through Different Communication Pathways: An Overview.
Intili G; Paladino L; Rappa F; Alberti G; Plicato A; Calabrò F; Fucarino A; Cappello F; Bucchieri F; Tomasello G; Carini F; Pitruzzella A
Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829474
[TBL] [Abstract][Full Text] [Related]
23. A Mechanistic Model of Gut-Brain Axis Perturbation and High-Fat Diet Pathways to Gut Microbiome Homeostatic Disruption, Systemic Inflammation, and Type 2 Diabetes.
Lew KN; Starkweather A; Cong X; Judge M
Biol Res Nurs; 2019 Jul; 21(4):384-399. PubMed ID: 31113222
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.
Giau VV; Wu SY; Jamerlan A; An SSA; Kim SY; Hulme J
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30441866
[TBL] [Abstract][Full Text] [Related]
25. Microbiota-Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling.
Boeri L; Perottoni S; Izzo L; Giordano C; Albani D
Adv Healthc Mater; 2021 Apr; 10(7):e2002043. PubMed ID: 33661580
[TBL] [Abstract][Full Text] [Related]
26. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease.
Sundman MH; Chen NK; Subbian V; Chou YH
Brain Behav Immun; 2017 Nov; 66():31-44. PubMed ID: 28526435
[TBL] [Abstract][Full Text] [Related]
27. Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis.
Ray SK; Mukherjee S
CNS Neurol Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37855297
[TBL] [Abstract][Full Text] [Related]
28. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
Kim N; Yun M; Oh YJ; Choi HJ
J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
[TBL] [Abstract][Full Text] [Related]
29. Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases.
Hirschberg S; Gisevius B; Duscha A; Haghikia A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242699
[TBL] [Abstract][Full Text] [Related]
30. Effect of gut microbiota-derived metabolites and extracellular vesicles on neurodegenerative disease in a gut-brain axis chip.
Kim NY; Lee HY; Choi YY; Mo SJ; Jeon S; Ha JH; Park SD; Shim JJ; Lee J; Chung BG
Nano Converg; 2024 Feb; 11(1):7. PubMed ID: 38340254
[TBL] [Abstract][Full Text] [Related]
31. Exploring the gut microbiota and its potential as a biomarker in gliomas.
Aljarrah D; Chalour N; Zorgani A; Nissan T; Pranjol MZI
Biomed Pharmacother; 2024 Apr; 173():116420. PubMed ID: 38471271
[TBL] [Abstract][Full Text] [Related]
32. Immune-microbiome interplay and its implications in neurodegenerative disorders.
Uniyal A; Tiwari V; Rani M; Tiwari V
Metab Brain Dis; 2022 Jan; 37(1):17-37. PubMed ID: 34357554
[TBL] [Abstract][Full Text] [Related]
33. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
Ghaisas S; Maher J; Kanthasamy A
Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
[TBL] [Abstract][Full Text] [Related]
35. The Gut-Brain Axis.
Mayer EA; Nance K; Chen S
Annu Rev Med; 2022 Jan; 73():439-453. PubMed ID: 34669431
[TBL] [Abstract][Full Text] [Related]
36. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis.
O'Mahony SM; Clarke G; Borre YE; Dinan TG; Cryan JF
Behav Brain Res; 2015 Jan; 277():32-48. PubMed ID: 25078296
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiome-mediated epigenetic regulation of brain disorder and application of machine learning for multi-omics data analysis.
Kaur H; Singh Y; Singh S; Singh RB
Genome; 2021 Apr; 64(4):355-371. PubMed ID: 33031715
[TBL] [Abstract][Full Text] [Related]
38. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences.
Zhao YF; Wei DN; Tang Y
Curr Neuropharmacol; 2021; 19(8):1354-1366. PubMed ID: 33588733
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach.
Rajanala K; Kumar N; Chamallamudi MR
Curr Neuropharmacol; 2021; 19(7):990-1006. PubMed ID: 33327916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
